Live Markets

Loading markets...

Skin checks reveal a high percentage of 'harmless' melanomas

By Josh Piers - June 17, 2022 - 5 Mins Read

melanoma skin cancer

Josh Piers

Related posts

Sniffing Chocolate Workout: The Ultimate Leg Day Fitness Hack

Sniffing Chocolate Workout: The Ultimate Leg Day Fitness Hack

July 13, 2026

Exercise for Brain Rot: Workouts Protect Memory From Doomscrolling

Exercise for Brain Rot: Workouts Protect Memory From Doomscrolling

July 08, 2026

Breaking: GLP-1 Weight Loss and Exercise Decline in Users

Breaking: GLP-1 Weight Loss and Exercise Decline in Users

July 02, 2026

5-Minute Workday Hack to Beat Sitting Health Risks

5-Minute Workday Hack to Beat Sitting Health Risks

June 25, 2026

Recent Posts

Editors Picks

Medicare GLP-1 Bridge: $50 Wegovy & Zepbound Copays

Medicare GLP-1 Bridge: $50 Wegovy & Zepbound Copays

By Dewey Olson - July 10, 2026 - 5 Mins Read

The Medicare GLP-1 Bridge program offers affordable weight loss drugs like Wegovy and Zepbound to eligible seniors for a $50 monthly copay.

Parental Phone Addiction Linked to Teen Anxiety by New Study

Parental Phone Addiction Linked to Teen Anxiety by New Study

By Dewey Olson - July 09, 2026 - 5 Mins Read

A groundbreaking July 2026 study reveals that parental phone distraction drives adolescent anxiety, leaving teens feeling dismissed and devalued.

Exercise for Brain Rot: Workouts Protect Memory From Doomscrolling

Exercise for Brain Rot: Workouts Protect Memory From Doomscrolling

By Brennan Forrest - July 08, 2026 - 5 Mins Read

A new July 2026 study reveals that regular exercise protects your working memory and reverses cognitive fatigue caused by endless video scrolling.

FDA-Bound Psilocybin Therapy Shows Lasting Relief for Depression

FDA-Bound Psilocybin Therapy Shows Lasting Relief for Depression

By Christian Webster - July 07, 2026 - 5 Mins Read

Compass Pathways reveals landmark 26-week data from its COMP360 Phase 3 trial, bringing a breakthrough psilocybin therapy closer to FDA approval.